NASDAQ: MEIP       Mei Pharma Inc
Last Price Today's Change   Day's Range   Trading Volume
3.45   +0.04 (1.17%)  3.355 - 3.48  604,847


Avg Volume (4 weeks):2,697,852
4 Weeks Range:3.19 - 4.46
4 Weeks Price Volatility (%):
52 Weeks Range:0.72 - 4.46
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

MEI Pharma Inc is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities are functioned through the region of US.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1344  4492  247  3007 

Top 10 Active Counters
 NIO 13.843+0.963 
 LK 1.38+1.38 
 SQQQ 6.396-0.084 
 AVP 5.60-0.05 
 TOPS 0.11-0.003 
 AIHS 1.57+0.32 
 AMD 56.24+2.81 
 AAL 11.33-0.66 
 F 5.89-0.20 
 ALT 22.904+5.874 
Partners & Brokers